Concord Corporation made the following purchases of investments during 2023 , the first year in which Concord invested in equity securities: 1. On January 15, it purchased 6,390 shares of Nirmala Corp.'s common shares at $23.80 per share plus commission of $1,407. 2. On April 1, it purchased 3,550 shares of Oxana Corp.'s common shares at $37 per share plus commission of $2,393. 3. On September 10, it purchased 4,970 shares of WTA Corp.'s preferred shares at $18.80 per share plus commission of $2,066. On May 20, 2023, Concord sold 2,130 of the Nirmala common shares at a market price of $25 per share less brokerage commissions of $2,027. The year-end fair values per share were as follows: Nirmala $21, Oxana $39, and WTA $20. The chief accountant of Concord tells you that Concord holds these investments with the intention of selling them to earn short-term profits from appreciation in their prices and accounts for them using the FV-NI model. Concord follows IFRS. Prepare the adjusting entry needed on December 31, 2023. (Credit account titles are automatically indented when the amount is entered. Do not indent manually. If no entry is required, select "No Entry" for the account titles and enter 0 for the amounts. List debit entry before credit entry.)